Breakingthrough FDA

Read more

‘Gender diversity and corporate boards’— Pharma leads the way!

Read more

US FDA raises concerns over Lupin’s plant at Pithampur

Read more

Lupin and Celon in agreement

Read more

Zydus completes phase I studies for its oral HIF inhibitor

Read more

Intas Pharmaceuticals launches biosimilar in Europe

Read more

Elder Pharma launches ‘Solo’ inhalers

Read more

Glenmark gets US approval for Ashlyna extended cycle oral contraceptive tablets

Read more

Cipla wins $ 189 m global tender

Read more

Mylan signs exclusive agreement with Gilead Sciences

Read more